NCT02256111View on ClinicalTrials.gov

EXTEND Exercise Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 13, 2015

Primary Completion Date

February 21, 2018

Study Completion Date

July 17, 2018

Conditions
Non-metastatic, Hormone naïve Prostate Cancer
Interventions
DRUG

Enzalutamide

DRUG

Androgen deprivation therapy

BEHAVIORAL

Supervised exercise training

Trial Locations (2)

10017

Memorial Sloan Kettering Cancer Center, New York

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER